They demonstrated that three out of seven patients with MMR deficiency had disease persistence, progression, and/or relapse, whereas two out of eight patients with no mutation or POLE mutations had a relapse of their disease [58]. This evidence concerns the gene POLE and mismatch repair cancer syndrome 1.